Concepedia

Paul L. Wood

PL

Statistics

Publications

192

Citations

10.2K

H-Index

60

Active since

1949

Affiliations

Douglas Mental Health University Institute(Current)

Lincoln Memorial University

Douglas College

Novartis (Switzerland)

Monsanto (United States)

Paul L. Wood is an author at Douglas Mental Health University Institute specializing in neuroscience, neuropharmacology, and neurochemistry.

ORCID

Publications per year

1949–2022

192

Publications

192

Neurobiology of 50-kHz ultrasonic vocalizations in rats: Electrode mapping, lesion, and pharmacology studies

Jeffrey Burgdorf, Paul L. Wood, Roger A. Kroes et al. · Behavioural Brain Research · 2007 · 347 citations

, , +12

Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor.

Richard B. Carter, Paul L. Wood, Scott Wieland et al. · PubMed · 1997 · 252 citations

, , +16

Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia

Dayan B. Goodenowe, Lisa L. Cook, Jun Liu et al. · Journal of Lipid Research · 2007 · 249 citations · Full text

, , +15

Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1β or IL-1RA but increases in the associated acute phase proteins IL-6, α2-macroglobulin and C-reactive protein

Julie A. Wood, Paul L. Wood, Randall Ryan et al. · Brain Research · 1993 · 245 citations

, , +17

Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease

Pierre Étienne, Yves Robitaille, Paul L. Wood et al. · Neuroscience · 1986 · 212 citations

, , +17

1–5 of 192